Welcome to our dedicated page for Albemarle news (Ticker: ALB), a resource for investors and traders seeking the latest updates and insights on Albemarle stock.
Albemarle Corporation (NYSE: ALB) is described as a global leader in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. News about Albemarle often highlights its activities in lithium and bromine, portfolio developments, organizational changes and financial performance, giving investors and observers insight into how the company manages its role in critical minerals and specialty chemicals.
On this page, readers can follow Albemarle’s earnings announcements, including quarterly results where the company discusses net sales, segment performance in areas such as Energy Storage, Specialties and Ketjen, cost and productivity initiatives, and outlook considerations based on observed lithium market price scenarios. Earnings-related news typically includes details on conference calls and webcasts that accompany these disclosures.
Company news also covers strategic portfolio actions, such as Albemarle’s agreement to sell a controlling stake in Ketjen’s refining catalyst solutions business to an affiliate of KPS Capital Partners and the planned sale of its 50% stake in the Eurecat joint venture to Axens SA. These items shed light on how Albemarle is focusing on its core businesses, improving financial flexibility and streamlining operations while retaining certain interests in catalyst-related activities.
Additional updates may describe organizational structure changes, leadership transitions, dividend declarations and Albemarle’s participation in critical mineral supply chains, including offtake and prepayment arrangements connected to lithium and cesium. By reviewing the news feed, users can track how Albemarle communicates its strategy, manages its portfolio and responds to market conditions over time.
Albemarle Corp. (NYSE: ALB), a global leader in lithium and bromine supply, has declared its 126th consecutive quarterly dividend of $0.405 per share. The dividend, with an annualized rate of $1.62, will be payable on July 1, 2025, to shareholders of record as of June 13, 2025.
Albemarle is a key player in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health sectors. The company maintains its position as a reliable global supplier of lithium and bromine, delivering advanced solutions to its customers.
Albemarle reported Q1 2025 results with net sales of $1.1 billion, marking a 21% decline from the previous year. The company posted net income of $41 million, with adjusted EBITDA of $267 million. Key highlights include:
The Energy Storage segment saw a 35% decrease in net sales to $525 million due to lower pricing. Specialties achieved 11% volume growth with net sales of $321 million, while Ketjen reported net sales of $231 million.
The company maintained its 2025 outlook despite market challenges, projecting total net sales between $4.9-$5.2 billion based on current lithium prices. Cost reduction efforts reached 90% of the targeted $350 million improvement goal. Capital expenditures for 2025 are expected to range from $700-800 million, representing a 50% reduction from 2024.
Cash from operations reached $545 million, including a $350 million customer prepayment. The company maintains strong liquidity of $3.1 billion with total debt of $3.5 billion.
Albemarle (NYSE: ALB), a global leader in essential elements for mobility, energy, connectivity and health, has scheduled its first quarter 2025 earnings release for Wednesday, April 30, 2025, after NYSE market close.
The company will host an earnings conference call on Thursday, May 1, at 8 a.m. ET. Investors can access the call via webcast through Albemarle's investor relations website or through direct dial-in numbers provided for both U.S. & Canada (toll-free) and international participants.
A webcast replay will be made available on Albemarle's website following the event. The company, known for its reliable global supply of lithium and bromine, focuses on developing advanced solutions for customers while prioritizing sustainability and resilience.
Albemarle (NYSE: ALB) has declared a quarterly common stock dividend of $0.405 per share, maintaining an annualized rate of $1.62. The dividend will be payable on April 1, 2025, to shareholders of record as of March 14, 2025.
Albemarle, a global leader in transforming essential resources into critical ingredients for mobility, energy, connectivity and health, specializes in providing reliable and high-quality global supply of lithium and bromine for advanced customer solutions.
Albemarle (NYSE: ALB), a global leader in essential elements, has announced its participation in two major investor conferences in February 2025. Kent Masters, chairman and CEO, will present at the BMO Capital Markets 2025 Global Metals, Mining & Critical Materials Conference on February 24 at 3 p.m. ET. Additionally, Neal Sheorey, CFO, will participate in a fireside chat at the BofA Securities 2025 Global Agriculture and Materials Conference on February 26 at 7:30 a.m. ET.
Both events will be accessible via live webcasts through Albemarle's investor relations website, with replay options available after the presentations. Albemarle, as a leading provider of lithium and bromine globally, focuses on transforming essential resources into critical ingredients for mobility, energy, connectivity, and health sectors.
Albemarle (NYSE: ALB) reported Q4 2024 results with net sales of $1.2 billion, down 48% year-over-year, and net income of $75 million ($0.29 per diluted share). The company posted an adjusted diluted loss per share of ($1.09).
Full-year 2024 performance showed net sales of $5.4 billion, with Energy Storage sales volumes up 26%. However, the company recorded a net loss of $1.2 billion, or ($11.20) per diluted share, including restructuring charges and asset write-offs. Full-year adjusted EBITDA was $1.1 billion, with cash from operations of $702 million.
For 2025, Albemarle is reducing capital expenditures by $100 million to $700-800 million, representing a more than 50% year-over-year reduction. The company is implementing cost reduction measures, optimizing its conversion network, and expects to achieve breakeven free cash flow in 2025.
Albemarle (NYSE: ALB), a global leader in essential elements for mobility, energy, connectivity and health, has scheduled its fourth-quarter 2024 earnings release for Wednesday, February 12, 2025, after NYSE market close. The company will host a conference call to discuss the results on Thursday, February 13, at 8:00 a.m. ET.
The earnings call will be accessible via webcast through Albemarle's investor relations website and through direct dial-in options. U.S. & Canada participants can join toll-free at 1-800-590-8290, while international callers can dial 1-240-690-8800 using the conference ID: ALBQ4. A replay of the webcast will be made available on the company's website after the event.
Albemarle (NYSE: ALB), a global leader in essential elements, announced that Eric Norris, chief commercial officer, will participate in a fireside chat at the Deutsche Bank Lithium & Battery Supply Chain Conference on December 4, 2024. The 20-minute session is scheduled for 8:00 AM EST.
The event will be accessible via webcast through Albemarle's investor relations website, with a replay available for 180 days. Albemarle specializes in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health, with a focus on global lithium and bromine supply.
Albemarle (NYSE: ALB) reported third-quarter 2024 results with net sales of $1.4 billion and a net loss of ($1.1) billion, or ($9.45) per diluted share. The loss included $861 million in pre-tax charges primarily from capital project asset write-offs. Energy Storage and Specialties volumes increased by 16% and 4% respectively. The company announced cost-saving initiatives including a 6-7% global workforce reduction and transition to an integrated functional model, expecting annual savings of $300-400 million. FY2025 capital expenditures will be reduced by approximately 50% to $800-900 million. Albemarle maintains its full-year 2024 outlook despite lower market pricing, supported by cost improvements and higher volumes.